OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 12 citing articles:

Trends in epidemiology of dyslipidemias in India
Sonali Sharma, Kiran Gaur, Rajeev Gupta
Indian Heart Journal (2024) Vol. 76, pp. S20-S28
Open Access | Times Cited: 11

Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond
Maya Safarova, Tia Bimal, Daniel Soffer, et al.
American Journal of Preventive Cardiology (2024) Vol. 19, pp. 100701-100701
Open Access | Times Cited: 8

Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
Michael J. Wilkinson, Norman E. Lepor, Erin D. Michos
Journal of the American Heart Association (2023) Vol. 12, Iss. 11
Open Access | Times Cited: 14

Low-Density Lipoprotein Cholesterol Control as a Performance Measure
Sneha S. Jain, Megan Skye, Natasha Din, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 13, pp. 1272-1275
Closed Access | Times Cited: 3

Closing the Gaps in Care of Dyslipidemia: Revolutionizing Management with Digital Health and Innovative Care Models
Samuel J Apple, Rachel Clark, Jonathan Daich, et al.
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 12, pp. 350-350
Open Access | Times Cited: 4

Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024
Timothy Abrahams, Stephen J. Nicholls, Adam J. Nelson
Medical Clinics of North America (2024) Vol. 108, Iss. 3, pp. 441-453
Closed Access | Times Cited: 1

LOGAN-CV: A Prospective Study of a Multifaceted Intervention Targeting United States Clinicians to Improve Guideline-Based Management of Lipid-Lowering Therapy
J Nikki McKoy, Bethany Kalich, Laura Greene, et al.
Advances in Therapy (2023) Vol. 41, Iss. 1, pp. 451-463
Open Access | Times Cited: 2

Education, urbanicity of residence, and cardiometabolic biomarkers among middle-aged and older populations in the US, Mexico, China, and India
Chihua Li, Yuan S. Zhang, Grace A. Noppert, et al.
SSM - Population Health (2024) Vol. 28, pp. 101716-101716
Open Access

Efficacy of Alirocumab, Evolocumab, and Inclisiran in Patients with Hypercholesterolemia at Increased Cardiovascular Risk
Renata Rajtar-Salwa, Beata Bobrowska, Sylwia Socha, et al.
Medicina (2024) Vol. 60, Iss. 7, pp. 1124-1124
Open Access

Low-Density Lipoprotein Cholesterol Testing Following Myocardial Infarction Hospitalization Among Medicare Beneficiaries
Lisandro D. Colantonio, Zhixin Wang, Jenna Jones, et al.
JACC Advances (2023) Vol. 3, Iss. 1, pp. 100753-100753
Open Access | Times Cited: 1

Groups Urge a Return to LDL-C Monitoring as a Quality Metric
Bridget M. Kuehn
Circulation (2023) Vol. 148, Iss. 22, pp. 1812-1813
Closed Access

Page 1

Scroll to top